Spots Global Cancer Trial Database for microsatellite stable colorectal cancer
Every month we try and update this database with for microsatellite stable colorectal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer | NCT03104439 | Microsatellite ... Pancreatic Canc... MSI High Colore... | Nivolumab Ipilimumab Radiation Thera... | 18 Years - | Massachusetts General Hospital | |
| Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. | NCT03891953 | Carcinoma, Non-... Melanoma Nasopharyngeal ... Microsatellite ... Triple Negative... | DKY709 PDR001 | 18 Years - | Novartis | |
| A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors | NCT05716295 | Advanced or Met... | MDK-703 Checkpoint Inhi... | 18 Years - 99 Years | Medikine, Inc. | |
| A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors | NCT05716295 | Advanced or Met... | MDK-703 Checkpoint Inhi... | 18 Years - 99 Years | Medikine, Inc. | |
| Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer | NCT03658772 | Microsatellite ... | grapiprant grapiprant and ... | 18 Years - | Arrys Therapeutics | |
| Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034) | NCT03473925 | Solid Tumors Non-small Cell ... Castration Resi... Microsatellite ... | Navarixin Pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
| NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors | NCT04332653 | Any Advanced So... Triple Negative... Non Small Cell ... Small Cell Lung... Microsatellite ... Pancreatic Canc... Ovarian Cancer | NT-I7 pembrolizumab (... | 18 Years - | NeoImmuneTech | |
| GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma | NCT04060342 | Pancreatic Aden... Esophageal Aden... Esophageal Squa... Gastric Adenoca... Gastroesophagea... Triple Negative... Castration-resi... Microsatellite ... Non-small Cell ... Small-cell Lung... Head and Neck S... Urothelial Carc... Renal Cell Carc... Hepatocellular ... | GB1275 nab-paclitaxel ... pembrolizumab | 18 Years - | Gossamer Bio Inc. | |
| GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma | NCT04060342 | Pancreatic Aden... Esophageal Aden... Esophageal Squa... Gastric Adenoca... Gastroesophagea... Triple Negative... Castration-resi... Microsatellite ... Non-small Cell ... Small-cell Lung... Head and Neck S... Urothelial Carc... Renal Cell Carc... Hepatocellular ... | GB1275 nab-paclitaxel ... pembrolizumab | 18 Years - | Gossamer Bio Inc. | |
| A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread | NCT02060188 | Microsatellite ... Microsatellite ... Mismatch Repair... Mismatch Repair... | Ipilimumab Nivolumab Cobimetinib Daratumumab BMS-986016 | 18 Years - | Bristol-Myers Squibb | |
| Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors | NCT04301011 | Solid Tumor Microsatellite ... HPV Positive Or... Cervical Cancer Melanoma (Skin) Cutaneous Squam... Mesothelioma Renal Cell Carc... Oropharynx Canc... | TBio-6517 Pembrolizumab | 18 Years - | Turnstone Biologics, Corp. | |
| Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer | NCT03104439 | Microsatellite ... Pancreatic Canc... MSI High Colore... | Nivolumab Ipilimumab Radiation Thera... | 18 Years - | Massachusetts General Hospital | |
| Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034) | NCT03473925 | Solid Tumors Non-small Cell ... Castration Resi... Microsatellite ... | Navarixin Pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
